Great Expectations

The vaccine push hit a bit of a speed bump Tuesday following news that Johnson & Johnson temporarily paused its COVID-19 vaccine trial after an unexplained illness, reminiscent of a similar setback for AstraZeneca last month. "We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said, adding that "the participant’s illness is being reviewed